Improved patient outcomes resulting from significant advances in cancer therapies—although a triumph—have also created a new clinical imperative to address long-term sequelae of cancer treatments in survivors. In this interactive forum, you will hear expert perspectives on:
- Common root causes of late endocrine effects due to cancer treatment in survivors of childhood cancer and the importance of lifelong monitoring for their development
- Strategies to address barriers to growth hormone deficiency treatment adherence
- Challenges of mitigating obesity and diabetes mellitus in cancer survivors
*Attendees must be registered for ENDO 2021 to participate.
1 upcoming events, beginning 03/22/2021More Information